Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-24

Clinical Trial Update: Safety of Insulin Detemir in Children With Type 1 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update assessing the safety of insulin detemir in children with Type 1 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levemir (insulin detemir)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED